Friday, 21 May 2010 18:39

Fosamax

Written by Law Offices Of Gary Green

Fosamax has been widely used to prevent or treat osteoporosis. It is also used for the treatment of Paget’s Disease. Fosamax has been associated with the development of bone loss in the jaw, also called osteonecrosis of the jaw (ONJ) or “jawbone death.” Criteria for Fosamax cause of action include:

  • Diagnosed with osteoporosis or Paget’s Disease
  • No kidney disease.
  • Development of osteonecrosis of the jaw (ONJ)
  • Long-term use of Fosamax
  • Atrial Fibrillation
  • Esophageal Tumors and/or cancer
  • Unusual Bone Fractures
  • Severe Bone, Joint and Muscle Pain

If you or someone you know suffered bone loss in the jaw after taking Fosamax, contact Law Offices of Gary Green toll free at 1-888-4GARYGREEN or send us an e-mail at ggreen@gGreen.com to discuss your legal options without obligation.